BIOTECH

BIOTECH

Forbes Australia recognizes Prota Therapeutics for making waves in Australia’s startup scene at the moment

June 18, 2024 – (Forbes Australia) – Founder and CEO Mimi Tang has spent almost...

Read more

BIOTECH

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments

Prota Therapeutics Pty Ltd (Prota), an Australian biotechnology company focused on the development of novel...

Read more

BIOTECH

Stalicla Secures $17.4 Million in Series B Financing

Stalicla SA, a clinical-stage biopharmaceutical company advancing precision medicine pipelines for neuropsychiatric and neurological disorders,...

Read more

BIOTECH

Spexis provides business update and announces financial results for the first half of 2023

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases...

Read more

BIOTECH

Spexis announces USD $2.5 million capital commitment to support the upcoming Phase 3 ColiFin® studies

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases...

Read more